India’s Domestic Drug Makers Welcome CL For Bayer’s Nexavar
This article was originally published in PharmAsia News
Executive Summary
India-based drug makers welcomed the decision to grant Natco Pharma the nation’s first compulsory license while multinationals denounced it as arbitrary and a discouragement for innovation.